Workflow
Payroll
icon
Search documents
Why Paychex Stock Fell on Tuesday
Yahoo Finance· 2025-09-30 17:21
Key Points Revenue landed roughly in line with expectations, and EPS edged past the consensus forecast. The company's outlook may have disappointed some investors. 10 stocks we like better than Paychex › Shares of Paychex (NASDAQ: PAYX) fell as much as 7.4% on Tuesday morning but were down about 4% as of 11 a.m. ET after the payroll, benefits, and human-resources manager reported fiscal first-quarter results. The stock's slide looks to be tied to revenue merely matching the Street consensus and to ...
X @Avalanche🔺
Avalanche🔺· 2025-09-29 20:00
Don’t wait days for payroll.With blockchain, payouts land in minutes anywhere in the world.Hear how @franklinpayroll × @rise_pay × Avalanche are reimagining payroll in an upcoming space hosted by @cryptoreine. https://t.co/aiQaUDo4BS ...
Paychex, Inc. (NASDAQ:PAYX) Quarterly Earnings Preview
Financial Modeling Prep· 2025-09-29 09:00
Earnings Expectations: Analysts predict an EPS of $1.21 and revenue of $1.54 billion.Market Valuation Metrics: Paychex showcases a P/E ratio of 27.87 and a price-to-sales ratio of 8.29.Financial Stability: The company maintains a current ratio of 1.28, indicating its ability to cover short-term liabilities.Paychex, Inc. (NASDAQ:PAYX) is a leading provider of payroll, human resource, and benefits outsourcing services for small to medium-sized businesses. The company is set to release its quarterly earnings o ...
NSP INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Insperity, Inc. (NYSE: NSP) and Encourages Investors with Substantial Losses to Contact the Firm
Prnewswire· 2025-09-16 03:21
Company Overview - Insperity, Inc. is a human resources and business solutions company that provides payroll, benefits, compliance, and talent management services to small and midsize businesses across the United States [3]. Allegations and Financial Impact - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Insperity due to allegations of providing potentially misleading business information to the investing public [1]. - On August 1, 2025, Insperity disclosed a 70% year-over-year decline in earnings per share for the second quarter of 2025, attributing this decline to rising pharmacy expenses, increased benefit costs, and large insurance claims [4]. - Following the earnings announcement, Insperity's stock price fell by $14.51 per share, or 24.35%, closing at $45.07 per share on August 1, 2025 [4]. - The company also revised down its full-year earnings guidance for 2025 [4].